The Semaglutide Study

NCT06420739 · Active, not recruiting

Last updated 2026-05-28

This study tests whether semaglutide reduces the risk of having a full stomach during a medical procedure in adults undergoing fasting.

Status Active, not recruiting Ongoing, but no longer enrolling new participants.

Type Observational

Participants 100 people

Who can join Ages 18+ · all sexes

Timeline Started 2024-03 · est. completion 2026-03

Where 1 site · Canada

What this study is testing ClinicalTrials.gov NCT06420739 ↗

Description as written by the study sponsor.

The primary goal of this study is to evaluate the incidence of "full stomach" in fasting elective surgical patients on Semaglutide medication. The other goals are to study the impact of the time interval since the last dose of the medication on the incidence of full stomach and to develop evidence-based recommendations for the perioperative management of these patients.

Treatments tested

Gastric Ultrasound Diagnostic test

Bedside Gastric Ultrasound to determine the volume and nature of gastric content in patients before their surgery.

Main thing measured	Incidence of full stomach.
Sponsor	University Health Network, Toronto
Conditions studied	Fasting
GLP-1 drugs	semaglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT06420739 ↗